These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16026306)

  • 1. Cannabinoids.
    López-Rodríguez ML
    Mini Rev Med Chem; 2005 Jul; 5(7):607. PubMed ID: 16026306
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic potential of cannabinoid receptor ligands: current status.
    Singh J; Budhiraja S
    Methods Find Exp Clin Pharmacol; 2006 Apr; 28(3):177-83. PubMed ID: 16810344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglial Cannabinoid CB
    Xu K; Wu Y; Tian Z; Xu Y; Wu C; Wang Z
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focus on cannabinoids and synthetic cannabinoids.
    Le Boisselier R; Alexandre J; Lelong-Boulouard V; Debruyne D
    Clin Pharmacol Ther; 2017 Feb; 101(2):220-229. PubMed ID: 27861784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoids ameliorate pain and reduce disease pathology in cerulein-induced acute pancreatitis.
    Michalski CW; Laukert T; Sauliunaite D; Pacher P; Bergmann F; Agarwal N; Su Y; Giese T; Giese NA; Bátkai S; Friess H; Kuner R
    Gastroenterology; 2007 May; 132(5):1968-78. PubMed ID: 17484889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoids for the treatment of inflammation.
    Ashton JC
    Curr Opin Investig Drugs; 2007 May; 8(5):373-84. PubMed ID: 17520866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset.
    Shoemaker JL; Seely KA; Reed RL; Crow JP; Prather PL
    J Neurochem; 2007 Apr; 101(1):87-98. PubMed ID: 17241118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The therapeutic potential of the cannabinoids in neuroprotection.
    Grundy RI
    Expert Opin Investig Drugs; 2002 Oct; 11(10):1365-74. PubMed ID: 12387700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Research progress of role of cannabinoid receptor in fibrosis].
    Li S; Wang L; Liu M; Gao Y; Tian Z; Jiang S; Zhang M; Guan D
    Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):136-8. PubMed ID: 24742582
    [No Abstract]   [Full Text] [Related]  

  • 10. Excitotoxicity in a chronic model of multiple sclerosis: Neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation.
    Docagne F; Muñetón V; Clemente D; Ali C; Loría F; Correa F; Hernangómez M; Mestre L; Vivien D; Guaza C
    Mol Cell Neurosci; 2007 Apr; 34(4):551-61. PubMed ID: 17229577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid-mediated elevation of intracellular calcium: a structure-activity relationship.
    Rao GK; Kaminski NE
    J Pharmacol Exp Ther; 2006 May; 317(2):820-9. PubMed ID: 16436496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and testing of novel classical cannabinoids: exploring the side chain ligand binding pocket of the CB1 and CB2 receptors.
    Nadipuram AK; Krishnamurthy M; Ferreira AM; Li W; Moore BM
    Bioorg Med Chem; 2003 Jul; 11(14):3121-32. PubMed ID: 12818675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid receptor subtypes 1 and 2 mediate long-lasting neuroprotection and improve motor behavior deficits after transient focal cerebral ischemia.
    Schmidt W; Schäfer F; Striggow V; Fröhlich K; Striggow F
    Neuroscience; 2012 Dec; 227():313-26. PubMed ID: 23069763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of CP55,940 on mechanosensory spinal neurons following chronic inflammation.
    Choong KC; Su X; Urban MO
    Neurosci Lett; 2007 Mar; 414(2):105-9. PubMed ID: 17194542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological basis of cannabinoid medicines.
    Keimpema E; Di Marzo V; Harkany T
    Science; 2021 Dec; 374(6574):1449-1450. PubMed ID: 34914498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain cannabinoid systems as targets for the therapy of neurological disorders.
    Consroe P
    Neurobiol Dis; 1998 Dec; 5(6 Pt B):534-51. PubMed ID: 9974182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3'-functionalized adamantyl cannabinoid receptor probes.
    Ogawa G; Tius MA; Zhou H; Nikas SP; Halikhedkar A; Mallipeddi S; Makriyannis A
    J Med Chem; 2015 Apr; 58(7):3104-16. PubMed ID: 25760146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of endocannabinoid system in physiological and pathological processes in the eye].
    Nadolska K; Goś R
    Klin Oczna; 2008; 110(10-12):392-6. PubMed ID: 19195174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoids in pain and inflammation.
    Mbvundula EC; Rainsford KD; Bunning RA
    Inflammopharmacology; 2004; 12(2):99-114. PubMed ID: 15265314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic cannabinoids: analysis and metabolites.
    Elsohly MA; Gul W; Wanas AS; Radwan MM
    Life Sci; 2014 Feb; 97(1):78-90. PubMed ID: 24412391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.